Specialty Pharma Journal Specialty, Precision & Technology
WASHINGTON, Aug. 12, 2016 /PRNewswire-USNewswire/ — Targeting a single protein, called SUPT4H1, reduces the levels of the three toxic entities created by the C9orf72 gene expansion, the most common genetic cause of ALS, according to a study published in the journal Science. The finding suggests that SUPT4H1 may be a …
Tag Archives: ALS Association
August, 2016
July, 2016
-
20 July
ALS Association and ALS Finding a Cure Provide Funding for Amylyx’s Mid-Stage Combo Trial
Washington, D.C. and Cambridge, Mass. (July 20, 2016) — The ALS Association and Amylyx Pharmaceuticals based in Cambridge, Mass. are pleased to announce that The ALS Association and ALS Finding a Cure® are jointly providing funding to support a Phase II trial of a potential new therapeutic approach being developed …
February, 2016
-
10 February
$1 Million Investment to Launch Grand Challenge to Develop a TDP43 Biomarker for ALS
WASHINGTON, Feb. 10, 2016 /PRNewswire-USNewswire/ — The ALS Association, in partnership with ALS Finding a Cure, is pleased to announce the Grand Challenge to generate a biomarker to track TDP43 aggregation. The successful team(s) with the most developed plan will receive up to a $1 million investment. ALS is a progressive …